Synopsys Stock Today

SNPS Stock  USD 547.74  0.00  0.00%   

Performance

3 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 3

 
High
 
Low
Very Low
Synopsys is selling for under 547.74 as of the 28th of November 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 547.74. Synopsys has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Note, on November 8, 2024, Representative Byron Donalds of US Congress acquired under $15k worth of Synopsys's common stock.
Business Domain
Software & Services
IPO Date
26th of February 1992
Category
Technology
Classification
Information Technology
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company was incorporated in 1986 and is headquartered in Mountain View, California. Synopsys operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 153.61 M outstanding shares of which 2.61 M shares are at this time shorted by private and institutional investors with about 2.75 trading days to cover. More on Synopsys

Moving together with Synopsys Stock

  0.86S SentinelOnePairCorr
  0.73NN Nextnav Acquisition CorpPairCorr

Moving against Synopsys Stock

  0.56FAAS DigiAsia Corp Symbol ChangePairCorr
  0.55MQ MarqetaPairCorr
  0.47VRAR Glimpse GroupPairCorr

Synopsys Stock Highlights

ESG Sustainability
Environmental
Governance
Social
President CEOSassine Ghazi
Business ConcentrationApplication Software, Software - Infrastructure, Information Technology, SP 500 Index, NASDAQ Composite, NASDAQ 100 Pre, Nasdaq CTA Artificial, NASDAQ 100 Technology, Nasdaq 100, Information Technology, Software, Software—Infrastructure, Technology (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.07590.14
Way Down
Pretty Stable
Asset Turnover0.670.65
Fairly Up
Very volatile
Gross Profit Margin0.920.91
Fairly Up
Slightly volatile
Total Current Liabilities3.6 B3.4 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total1.4 B1.3 B
Sufficiently Up
Slightly volatile
Total Assets12.5 B11.9 B
Sufficiently Up
Slightly volatile
Total Current Assets4.1 B3.9 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities2.1 BB
Sufficiently Up
Slightly volatile
Debt Levels
Synopsys can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Synopsys' financial leverage. It provides some insight into what part of Synopsys' total assets is financed by creditors.
Liquidity
Synopsys currently holds 687.8 M in liabilities with Debt to Equity (D/E) ratio of 0.12, which may suggest the company is not taking enough advantage from borrowing. Synopsys has a current ratio of 1.12, suggesting that it may have difficulties to pay its financial obligations when due. Note, when we think about Synopsys' use of debt, we should always consider it together with its cash and equity.

Total Cash From Operating Activities

2.06 Billion
Synopsys (SNPS) is traded on NASDAQ Exchange in USA. It is located in 675 Almanor Avenue, Sunnyvale, CA, United States, 94085 and employs 20,300 people. Synopsys is listed under Application Software category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 85.09 B. Synopsys conducts business under Software sector and is part of Information Technology industry. The entity has 153.61 M outstanding shares of which 2.61 M shares are at this time shorted by private and institutional investors with about 2.75 trading days to cover. Synopsys currently holds about 1.53 B in cash with 1.7 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.01.
Check Synopsys Probability Of Bankruptcy
Ownership Allocation
Synopsys shows a total of 153.61 Million outstanding shares. The majority of Synopsys outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Synopsys to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Synopsys. Please pay attention to any change in the institutional holdings of Synopsys as this could imply that something significant has changed or is about to change at the company. On November 8, 2024, Representative Byron Donalds of US Congress acquired under $15k worth of Synopsys's common stock.
Check Synopsys Ownership Details

Synopsys Stock Institutional Holders

InstituionRecorded OnShares
Norges Bank2024-06-30
2.1 M
Massachusetts Financial Services Company2024-09-30
M
Pictet Asset Manangement Sa2024-06-30
1.9 M
Sustainable Growth Advisers, Lp2024-09-30
1.8 M
Swedbank Ab2024-09-30
1.6 M
Ubs Asset Mgmt Americas Inc2024-09-30
1.5 M
Nuveen Asset Management, Llc2024-06-30
1.5 M
Northern Trust Corp2024-09-30
1.4 M
Ameriprise Financial Inc2024-06-30
1.4 M
Vanguard Group Inc2024-09-30
14.4 M
Blackrock Inc2024-06-30
12.8 M
View Synopsys Diagnostics

Synopsys Historical Income Statement

At this time, Synopsys' Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 1.6 B in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 527.8 M in 2024. View More Fundamentals

Synopsys Stock Against Markets

Synopsys Corporate Management

Shankar KrishnamoorthyHead DevelopmentProfile
Paul StraversPrincipal EngineerProfile
Shelagh GlaserChief OfficerProfile
Charlie MatarSenior GroupProfile
John KoeterSenior StrategyProfile
John RunkelGeneral Counsel and Corporate SecretaryProfile

Additional Tools for Synopsys Stock Analysis

When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.